Centene (CNC) Set to Announce Earnings on Tuesday
Centene (NYSE:CNC) will issue its quarterly earnings data before the market opens on Tuesday, April 23rd. Analysts expect the company to announce earnings of $1.32 per share for the quarter. Centene has set its FY 2019 guidance at $4.11-4.31 EPS and its FY19 guidance at $8.22-8.62 EPS.Parties interested in participating in the company’s conference call can do so using this link.
Centene (NYSE:CNC) last announced its quarterly earnings data on Tuesday, February 5th. The company reported $1.38 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.33 by $0.05. Centene had a net margin of 1.50% and a return on equity of 14.10%. The business had revenue of $16.56 billion for the quarter, compared to analyst estimates of $16.38 billion. During the same period last year, the business earned $0.49 EPS. The company’s revenue was up 29.3% on a year-over-year basis. On average, analysts expect Centene to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
Shares of CNC opened at $53.22 on Tuesday. Centene has a twelve month low of $49.56 and a twelve month high of $74.49. The firm has a market capitalization of $21.87 billion, a PE ratio of 15.03, a PEG ratio of 0.98 and a beta of 1.26. The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 0.60.
CNC has been the topic of a number of analyst reports. Cowen initiated coverage on shares of Centene in a report on Thursday, February 28th. They issued an “outperform” rating and a $77.00 price objective on the stock. Goldman Sachs Group lowered shares of Centene from a “conviction-buy” rating to a “buy” rating in a report on Monday, December 17th. Cantor Fitzgerald raised their price objective on shares of Centene from $72.50 to $82.50 and gave the company an “overweight” rating in a report on Monday, December 17th. Oppenheimer cut their price target on shares of Centene from $165.00 to $83.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 6th. Finally, ValuEngine lowered shares of Centene from a “hold” rating to a “sell” rating in a research note on Friday, February 8th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $76.87.
Centene Company Profile
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. The company's Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which covers dually eligible individuals, as well as aged, blind, or disabled programs.
Read More: Special Dividends
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.